COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,627 Articles (22,913 medRxiv, 8,714 bioRxiv)

Most recent first Previous |  Page 921: Articles 9201-9210  | Next

Evolutionary safety of death by mutagenesis
Lobinska, G. A., Pilpel, Y. T., Nowak, M. A.
10.1101/2022.03.10.483790 — Posted: 2022-03-10
More or less deadly? A mathematical model that predicts SARS-CoV-2 evolutionary direction.
Xu, Z., Zeng, Q.
10.1101/2022.03.10.483726 — Posted: 2022-03-10
SARS-CoV-2 Omicron variant is more stable than the ancestral strain on various surfaces
Chin, A., Lai, A., Peiris, M., Poon, L.
10.1101/2022.03.09.483703 — Posted: 2022-03-10
Thiopurines inhibit coronavirus Spike protein processing and incorporation into progeny virions
Pringle, E. S., Duguay, B. A., Bui-Marinos, M. P., Mulloy, R. P., Landreth, S. L., Desireddy, K. S., Dolliver, S. M., Ying, S., Caddell, T., Slaine, P. D., Bearne, S. L., Falzarano, D., Corcoran, J., Khaperskyy, D. A., McCormick, C.
10.1101/2022.03.10.483772 — Posted: 2022-03-10
Aerosolized Ad5-nCoV booster vaccination elicited potent immune response against the SARS-CoV-2 Omicron variant after inactivated COVID-19 vaccine priming
Zhang, Z., Wu, S., Liu, Y., Li, K., Fan, P., Song, X., Wang, Y., Zhao, Z., Zhang, X., Shang, J., Zhang, J., Xu, J., Li, Y., Li, Y., Zhang, J., Fu, K., Wang, B., Hao, M., Zhang, G., Long, P., Qiu, Z., Zhu, T., Liu, S., Zhang, Y., Shao, F., Lv, P., Yang, Y., Zhao, X., Sun, Y., Hou, L., Chen, W.
10.1101/2022.03.08.22271816 — Posted: 2022-03-10
The Acoustic Dissection of Cough: Diving into Machine Listening-based COVID-19 Analysis and Detection
Ren, Z., Chang, Y., Bartl-Pokorny, K. D., Pokorny, F. B., Schuller, B. W.
10.1101/2022.03.01.22271693 — Posted: 2022-03-10
SARS-CoV-2 genomic surveillance enables the identification of Delta/Omicron co-infections in Argentina.
Pisano, M. B., Sicilia, P., Zeballos, M., Lucca, A., Fernandez, F., Castro, G., Goya, S., Viegas, M., Lopez, L., Barbas, G., Re, V.
10.1101/2022.03.08.22270920 — Posted: 2022-03-10
Short-term drop in antibody titer after the third dose of SARS-CoV-2 BNT162b2 vaccine in adults
Herzberg, J., Fischer, B., Becher, H., Becker, A.-K., Honarpisheh, H., Strate, T., Knabbe, C.
10.1101/2022.03.07.22272028 — Posted: 2022-03-10
Trends, regional variation and clinical characteristics of recipients of antivirals and neutralising monoclonal antibodies for non-hospitalised COVID-19: a descriptive cohort study of 23.4 million people in OpenSAFELY
Green, A. C., Curtis, H. J., Higgins, R., Smith, R., Mehrkar, A., Inglesby, P., Mahalingasivam, V., Drysdale, H., DeVito, N., Croker, R., Rentsch, C. T., Bhaskaran, K., Andrews, C. D., Bacon, S. C., Davy, S., Dillingham, I., Evans, D., Fisher, L., Hickman, G., Hopcroft, L. E. M., Hulme, W. J., Massey, J., Morley, J., Morton, C. E., Park, R. Y., Walker, A. J., Ward, T., Wiedemann, M., Bates, C., Cockburn, J., Parry, J., Hester, F., Harper, S., Douglas, I. J., Evans, S. J., Tomlinson, L., MacKenna, B., Goldacre, B.
10.1101/2022.03.07.22272026 — Posted: 2022-03-10
Emergence and Spread of the SARS-CoV-2 Omicron Variant in Alberta Communities Revealed by Wastewater Monitoring
Hubert, C. R., Acosta, N., Waddell, B. J., Hasing, M. E., Qiu, Y., Fuzzen, M., Harper, N. B., Bautista, M. A., Gao, T., Papparis, C., Van Doorn, J., Du, K., Xiang, K., Chan, L., Vivas, L., Pradhan, P., McCalder, J., Low, K., England, W. E., Conly, J., Ryan, M. C., Achari, G., Hu, J., Cabaj, J. L., Sikora, C., Svenson, L., Zelyas, N., Servos, M., Meddings, J., Hrudey, S. E., Frankowski, K., Parkins, M. D., Pang, X., Lee, B. E.
10.1101/2022.03.07.22272055 — Posted: 2022-03-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).